Affimed N.V. (Nasdaq: AFMD), a clinical-stage immuno-oncology company committed to giving patients back their innate ability ...

Clinical data supporting mechanism of action reinforce potential as a novel cancer treatmentBRISBANE, Calif., March 25, 2025 ...

Abstract Highlights ORIC-944 is a potent, highly selective, orally bioavailable, allosteric inhibitor of PRC2 that demonstrates best-in-class drug properties, including potency, solubility, and ...

This presentation will highlight a preclinical dataset that provides insights into the role of inhibiting TGF-β in overcoming acquired KRAS-G12C-inhibitor drug-resistant KRAS-G12C-mutated lung cancer.

REDWOOD CITY, Calif., March 25, 2025 (GLOBE NEWSWIRE) -- (“Coherus,” NASDAQ: CHRS), a commercial-stage innovative oncology company, today announced that an abstract highlighting interim data from its ...

Abstract accepted for late-breaking poster presentation – -- EO-1022 is a potentially differentiated HER3 ADC being developed for the treatment of solid ...

Novel trispecific T cell engager, ZW209, demonstrates potent preclinical efficacy against DLL3-expressing tumors and an encouraging safety profile New antibody-drug conjugate (ADC) candidate, ZW327 ...

Lawrence school members on Monday reviewed the next steps for the school district, targeting opportunities for additional ...

Elizabeth Hobbs, an animated filmmaker based in London, utilized her dynamic, sketchy style to depict “The Debutante.” Her ...

Organizations haven't yet drawn business value from AI investments, and many feel AI is overhyped. Gartner analysts said ...

RMB Latitudes Art Fair has announced that its third edition is set to take place in the Shepstone Gardens, johannesburg, from 23-25 May 2025.Presented by Latitudes Online in partnership with Rand ...

For their creation called BlazeBlock, Sofia Taha, Kason Sonnenberg-Trent, and Charlie Pilgrim, have been named regional ...